Live
Home·Deals·Biopharmaceuticals·Sanofi acquires Dynavax Technologies
Sanofi acquires Dynavax Technologies (2026)
SEO URLwww.firestrike.ai/deals/dynavax-technologies-sanofi-acquisition-2026-7
acquisitionAnnounced · Feb 10, 2026BiopharmaceuticalsSource · CredibleArticle · Factual
Dynavax Technologies
Sanofi
Dynavax Technologies · Sanofi

Sanofi acquires Dynavax Technologies

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$2.2B
Target
Dynavax Technologies
Dynavax Technologies
NASDAQ: DVAX · Emeryville, California
Acquirer
Sanofi
Sanofi
Full Acquisition
Status
Completed

Sanofi agreed to acquire Dynavax Technologies. Reported deal value: $2.2B. Status: Completed. Sector: Biopharmaceuticals. Target headquarters context: Emeryville, California, United States.

This page summarizes publicly available information about the transaction as of 2026-02-10. Figures and status may change as filings and press coverage update.

Deal timeline

Announced
Feb 10, 2026 · manilatimes.net
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Biopharmaceuticals with a reported deal value of $2.2B. Figures and status may change as sources update.

Sources: manilatimes.net · Primary article · FireStrike proprietary index